Powering What's Next" event celebrates key milestones and the company's resilience as it enters its next chapter of innovation and ...

XyloCor Therapeutics, Inc. (XyloCor or the Company), a clinical-stage biopharmaceutical company focused on developing innovative therapies for cardiovascular disease, today announced the appointment ...

This year’s COP31 will play a crucial role in establishing a framework for the second Global Stocktake (GST2) in 2028, as well maintain momentum on climate action in a fracturing geopolitical ...